P53 Activator Peptides
The present invention relates to novel polypeptides that activate p53, and the polynucleotides encoding these p53 activator peptides. The present invention also relates to pharmaceutical compositions comprising the p53 activator peptides as well as methods of treating abnormal conditions, such as malignant tumors, with the methods comprising administering the pharmaceutical compositions of the present invention to a subject in need of treatment thereof.
Patents:WO 2,009,149,339
Inventor(s):
LU WUYUAN [US]; ZELLA DAVIDE [US]; LIU MIN [US]; LI CHANGQING [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents